文献速递脑血管病外科神经重症

脑脊液巨噬细胞移动抑制因子:动脉瘤性蛛网膜下腔出血后脑血管痉挛与临床结局的潜在预测指标

Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhage.
PubMed 文献 · J Neurosurg · 2019-10-04

这项前瞻性临床研究纳入25例动脉瘤性蛛网膜下腔出血(aSAH)和9例正常压力脑积水(NPH)患者,检测脑脊液巨噬细胞移动抑制因子(MIF)浓度。结果显示aSAH患者脑脊液MIF总浓度显著高于NPH患者,MIF峰值日与临床血管痉挛发生显著相关,且有延迟性脑缺血(DCI)者MIF浓度显著升高,但感染可能混杂该关联。

要点

  • aSAH患者脑脊液MIF浓度显著高于NPH患者。
  • MIF峰值出现日与临床血管痉挛发生显著相关。
  • 感染可能混杂MIF与血管痉挛/DCI的关联。

核心结论

  • 初步证据提示脑脊液MIF浓度与脑血管痉挛和延迟性脑缺血相关。
  • 临床感染存在时该结果可能受到混杂,需更大样本研究验证。

研究设计与样本

  • 前瞻性临床研究,在北岸大学医院纳入aSAH或正常压力脑积水(NPH)且置入脑室外引流管患者。
  • aSAH组25例,NPH组9例,检测脑脊液MIF浓度并与脑血管痉挛或DCI进行相关性分析。

主要发现

  • aSAH患者脑脊液MIF总浓度较NPH患者显著升高(24.4 ± 19.2 vs 2.3 ± 1.1 ng/ml,p < 0.0002)。
  • MIF峰值浓度出现日与临床血管痉挛发生显著相关(rho = 0.778,p < 0.0010)。
  • 有DCI证据者MIF浓度显著高于无DCI者(18.7 ± 4.93 vs 8.86 ± 1.28 ng/ml,p < 0.0025)。
  • 感染患者MIF浓度显著高于无感染者(16.43 ± 4.21 vs 8.5 ± 1.22 ng/ml,p < 0.0119)。

临床怎么用

  • 脑脊液MIF或可作为aSAH后血管痉挛和DCI的潜在生物标志物,但解读时需考虑感染影响。

局限性

  • 样本量小(aSAH组25例,NPH组9例),结论为初步证据。
  • 临床感染可能混杂MIF与血管痉挛/DCI的关联。
  • 需更大样本研究证实上述发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In patients with aneurysmal subarachnoid hemorrhage (aSAH), poor outcomes have been shown to be correlated with subsequent cerebral vasospasm (CV) and delayed cerebral ischemia (DCI). The identification of novel biomarkers may aid in the prediction of which patients are vulnerable to developing vasospasm, cerebral ischemia, and neurological deterioration. METHODS: In this prospective clinical study at North Shore University Hospital, patients with aSAH or normal pressure hydrocephalus (NPH) with external ventricular drains were enrolled. The concentration of macrophage migration inhibitory factor (MIF) in CSF was assessed for correlation with CV or DCI, the primary outcome measures. RESULTS: Twenty-five patients were enrolled in the aSAH group and 9 were enrolled in the NPH group. There was a significant increase in aggregate CSF MIF concentration in patients with aSAH versus those with NPH (24.4 ± 19.2 vs 2.3 ± 1.1 ng/ml, p < 0.0002). Incidence of the day of peak MIF concentration significantly correlated with the onset of clinical vasospasm (rho = 0.778, p < 0.0010). MIF concentrations were significantly elevated in patients with versus those without evidence of DCI (18.7 ± 4.93 vs 8.86 ± 1.28 ng/ml, respectively, p < 0.0025). There was a significant difference in MIF concentrations between patients with infection versus those without infection (16.43 ± 4.21 vs 8.5 ± 1.22 ng/ml, respectively, p < 0.0119). CONCLUSIONS: Preliminary evidence from this study suggests that CSF concentrations of MIF are correlated with CV and DCI. These results, however, could be confounded in the presence of clinical infection. A study with a larger patient sample size is necessary to corroborate these findings.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kwan K, Arapi O, Wagner KE, et al. Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019. PMID: 31585427. doi:10.3171/2019.6.JNS19613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。